Genmab ADR (NASDAQ: GMAB) is 2.06% higher on its value in year-to-date trading and has touched a low of $18.64 and a high of $31.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GMAB stock was last observed hovering at around $20.92 in the last trading session, with the day’s gains setting it 0.38%.
Currently trading at $21.30, the stock is 6.15% and 2.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.23 million and changing 1.82% at the moment leaves the stock -13.20% off its SMA200. GMAB registered -19.41% loss for a year compared to 6-month loss of -20.52%. The firm has a 50-day simple moving average (SMA 50) of $20.7074 and a 200-day simple moving average (SMA200) of $24.5401.
The stock witnessed a 5.29% gain in the last 1 month and extending the period to 3 months gives it a -5.21%, and is 12.11% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.96% over the week and 2.32% over the month.
Genmab ADR (GMAB) has around 2682 employees, a market worth around $13.53B and $3.12B in sales. Current P/E ratio is 12.16 and Fwd P/E is 12.12. Profit margin for the company is 36.30%. Distance from 52-week low is 14.30% and -33.19% from its 52-week high. The company has generated returns on investments over the last 12 months (21.67%).
with sales reaching $5.18B over the same period.The EPS is expected to shrink by -15.32% this year, but quarterly earnings will post 17.30% year-over-year. Quarterly sales are estimated to grow 25.11% in year-over-year returns.
Genmab ADR (GMAB) Top Institutional Holders
The shares outstanding are 635.40M, and float is at 635.39M with Short Float at 0.25%.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.334% of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.78 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.4744% and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2657 of the shares totaling 2.77 million with a market value of $69.61 million.
Genmab ADR (GMAB) Insider Activity
#####
